Matches in Wikidata for { <http://www.wikidata.org/entity/Q94352333> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q94352333 description "article scientifique publié en 2014" @default.
- Q94352333 description "wetenschappelijk artikel" @default.
- Q94352333 description "наукова стаття" @default.
- Q94352333 name "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 name "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 type Item @default.
- Q94352333 label "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 label "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 prefLabel "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 prefLabel "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 P1433 Q94352333-888C886C-0B9E-46F5-B6D6-7CE14E0E3698 @default.
- Q94352333 P1476 Q94352333-F5525D3E-DAB3-4BDF-8266-EAF22171E6C4 @default.
- Q94352333 P2093 Q94352333-0D3F4044-873B-4C1D-9888-923175A14AE9 @default.
- Q94352333 P2093 Q94352333-128D7E56-900D-41F3-8097-8B92DCA6F09A @default.
- Q94352333 P2093 Q94352333-75885F99-B034-4F9C-93F1-41654181C73E @default.
- Q94352333 P2093 Q94352333-8EA09525-F8A6-404A-A845-D7B3B9F97077 @default.
- Q94352333 P2093 Q94352333-E15AEEEA-2956-4718-BB14-E4A2380816CE @default.
- Q94352333 P304 Q94352333-92793785-DBEC-4FB6-9F66-AFE231DE61E0 @default.
- Q94352333 P31 Q94352333-2183385C-C716-44C4-8972-879B57B79B9F @default.
- Q94352333 P356 Q94352333-61D5CB9A-9DA5-4962-8F07-5042926838EC @default.
- Q94352333 P433 Q94352333-A482831E-69AC-4870-A04B-B7B409FC9296 @default.
- Q94352333 P478 Q94352333-9C5D91CF-863A-44F3-8840-AAD584D3E678 @default.
- Q94352333 P577 Q94352333-27FEBBF3-D4DE-4518-8863-35D0DCDDEC7B @default.
- Q94352333 P921 Q94352333-382FF3CC-1CD1-4885-8617-0FE6D38AA573 @default.
- Q94352333 P921 Q94352333-7E0B14FE-AAF8-4DB3-B6D6-150F051A16E5 @default.
- Q94352333 P921 Q94352333-9D13BEDD-2C7D-40DD-B58F-6119E40A0137 @default.
- Q94352333 P932 Q94352333-07DB30F7-D88F-4D71-93FE-0060E1753943 @default.
- Q94352333 P356 NOU237.4 @default.
- Q94352333 P1433 Q15724471 @default.
- Q94352333 P1476 "AT-04A RANDOMIZED PHASE II TRIAL OF VANDETANIB IN COMBINATION WITH CARBOPLATIN VERSUS CARBOPLATIN ALONE FOLLOWED BY VANDETANIB ALONE IN ADULTS WITH RECURRENT ANAPLASTIC ASTROCYTOMA" @default.
- Q94352333 P2093 "Howard Fine" @default.
- Q94352333 P2093 "Joanna Shih" @default.
- Q94352333 P2093 "Katherine Warren" @default.
- Q94352333 P2093 "Prakash Ambady" @default.
- Q94352333 P2093 "Teri Kreisl" @default.
- Q94352333 P304 "v8-v9" @default.
- Q94352333 P31 Q13442814 @default.
- Q94352333 P356 "10.1093/NEUONC/NOU237.4" @default.
- Q94352333 P433 "Suppl 5" @default.
- Q94352333 P478 "16" @default.
- Q94352333 P577 "2014-11-01T00:00:00Z" @default.
- Q94352333 P921 Q415588 @default.
- Q94352333 P921 Q42824440 @default.
- Q94352333 P921 Q486092 @default.
- Q94352333 P932 "4217819" @default.